Cargando…
Effects of Nefopam on Streptozotocin-Induced Diabetic Neuropathic Pain in Rats
BACKGROUND: Nefopam is a centrally acting non-opioid analgesic agent. Its analgesic properties may be related to the inhibitions of monoamine reuptake and the N-methyl-D-aspartate (NMDA) receptor. The antinociceptive effect of nefopam has been shown in animal models of acute and chronic pain and in...
Autores principales: | Nam, Jae Sik, Cheong, Yu Seon, Karm, Myong Hwan, Ahn, Ho Soo, Sim, Ji Hoon, Kim, Jin Sun, Choi, Seong Soo, Leem, Jeong Gil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Pain Society
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196497/ https://www.ncbi.nlm.nih.gov/pubmed/25317281 http://dx.doi.org/10.3344/kjp.2014.27.4.326 |
Ejemplares similares
-
Rediscovery of Nefopam for the Treatment of Neuropathic Pain
por: Kim, Kyung Hoon, et al.
Publicado: (2014) -
Use of Nefopam in Perioperative Pain Management; Keeping Nefopam in between
por: Choi, Jeong Il
Publicado: (2016) -
The Potential Role of Intrathecal Nefopam in the Management of Neuropathic Pain
por: Ghobadifar, Mohamed Amin, et al.
Publicado: (2014) -
Mechanical Antiallodynic Effect of Intrathecal Nefopam in a Rat Neuropathic Pain Model
por: Kim, Kyung-Hoon, et al.
Publicado: (2015) -
Nefopam: Another Pragmatic Analgesic in Managing Chronic Neuropathic Pain
por: Nair, Abhijit S
Publicado: (2019)